News

Add JB Chemicals & Pharma Ltd For Target Rs.1,808 - Yes Securities We hosted investors for a visit to JB Chemicals' Daman lozenges facility to better understand the outlook for lozenges business and factors that can drive growth. Key takeaways include 1) Geographical expansion with same customer, tech transfer for customer owned product and owned product push are three main levers of growth 2) Companies want to do quick marketing and not earlier practice of filing of own dossiers which is leading to quicker but durable demand 3) Overall 50% by volume is ...
Add JB Chemicals & Pharma Ltd For Target Rs.1,808 - Yes Securities
Add JB Chemicals & Pharma Ltd For Target Rs.1,808 - Yes Securities
Source: Yes Securities Ltd.
2024-05-28 02:20:05 pm
Reduce JB Chemicals & Pharmaceuticals Ltd For Target Rs. 1,713 - Elara Capital   Lower growth; richer valuation Weak Q3F23 results    JB Chemicals & Pharmaceuticals’ (JBCP IN) Q3FY24 revenue and EBITDA came in 4% and 7% below our estimates, respectively. PAT was 12% lower due to higher depreciation, finance cost and tax rate. Domestic business was as expected, while a 7% decline in the CDMO business and a 1% drop in formulations exports led to the miss. ...
Reduce JB Chemicals & Pharmaceuticals Ltd For Target Rs. 1,713 - Elara Capital
Reduce JB Chemicals & Pharmaceuticals Ltd For Target Rs. 1,713 - Elara Capital
Source: Elara Capital
2024-03-08 09:21:22 am
Reduce JB Chemicals & Pharmaceuticals Ltd Target Rs.1,713 - Elara Capital Lower growth; richer valuation Weak Q3F23 results    JB Chemicals & Pharmaceuticals’ (JBCP IN) Q3FY24 revenue and EBITDA came in 4% and 7% below our estimates, respectively. PAT was 12% lower due to higher depreciation, finance cost and tax rate. Domestic business was as expected, while a 7% decline in the CDMO business and a 1% drop in formulations exports led to the miss. India business – Growth settling at lower levels Reported domestic business g...
Reduce JB Chemicals & Pharmaceuticals Ltd Target Rs.1,713 - Elara Capital
Reduce JB Chemicals & Pharmaceuticals Ltd Target Rs.1,713 - Elara Capital
Source: Elara Capital
2024-02-26 12:59:02 pm
JB Chemicals & Pharmaceuticals trades higher on the BSE JB Chemicals & Pharmaceuticals is currently trading at Rs. 1472.90, up by 6.80 points or 0.46% from its previous closing of Rs. 1466.10 on the BSE. The scrip opened at Rs. 1492.85 and has touched a high and low of Rs. 1498.95 and Rs. 1472.25 respectively. So far 2211 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1554.80 on 07-Dec-2023 and a 52 week low of Rs. 914.65 on 22-May-2023. Last one week high and l...
JB Chemicals & Pharmaceuticals trades higher on the BSE
JB Chemicals & Pharmaceuticals trades higher on the BSE
Source: Accord Fintech
2023-12-20 02:36:52 pm
Company Update : JB Chemicals & Pharmaceuticals By Elara Capital More acquisitions; organic growth concerns persist As per media reports, JB Chemicals & Pharmaceuticals (JBCP IN) is set to acquire a portfolio of eye care (ophthalmology) products from Novartis India. Media reports suggest that portfolio has an annual revenue of INR 4-5bn and the price will be ~INR 10bn. This works out to 2.0-2.5x sales, broadly in line with the recent deals in the domestic market. We downgraded our rating on JBCP to Reduce after the Q2FY24 results based on rich valua...
Company Update : JB Chemicals & Pharmaceuticals By Elara Capital
Company Update : JB Chemicals & Pharmaceuticals By Elara Capital
Source: Elara Capital
2023-12-14 11:43:33 am